|
Tuesday, March 27 — 8:00 AM — CC 6 C/F
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt
in the toolbar above as feedback: | |  |
|
Section B - GYNECOLOGIC PATHOLOGY
Chaired by: Mark H. Stoler and Michelle S. Hirsch
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Dermatofibrosarcoma Protuberans of the Vulva: A Clinicopathological Study of 11 Cases
(890)
M Edelweiss, A Malpica The University of Texas MD Anderson Cancer Center, Houston, TX
|  Add |
| 8:15 |
Distribution of High-Risk HPV Subtypes in HGSIL Cervical Lesions from a Midwest, Affluent-Suburban, Screened Population
(865)
SK Bhagavathi, E Odish, S Forbes, NS Goldstein William Beaumont Hospital, Royal Oak, MI
| Add |
| 8:30 |
ProEx C as a Marker of HPV-Associated Squamous Lesions of the Cervix
(863)
RE Badr, AE Walts, S Bose Cedars-Sinai Medical Center, Los Angeles, CA
| Add |
| 8:45 |
Can HPV 16 Typing Adjudicate the Accuracy of Cervical Biopsy Interpretation?
(901)
MT Galgano, PE Castle, MH Stoler University of Virginia, Charlottesville, VA; National Cancer Institute, NIH, DHHS, Bethesda, MD
| Add |
| 9:00 |
Therapeutic and Antiangiogenic Activities of Cyclooxygenase-2 Inhibitor in High Grade Squamous Intraepithelial Lesions of the Cervix — Histologic and Immunohistochemical Follow up
(939)
HC Li, H Scott, KR Geisinger, JO Cappellari, BE Miller Wake Forest University Baptist Medical Center, Winston-Salem, NC
| Add |
| 9:15 |
Sentinel Lymph Node Evaluation in Cervical Cancer
(894)
ED Euscher, A Malpica, MT Deavers The University of Texas M.D. Anderson Cancer Center, Houston, TX
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
Coffee Break sponsored by PathSync
| |
| 11:00 |
Gastric Morphology and Immunophenotype Predict Poor Outcome in Cases of Mucinous Adenocarcinoma of the Uterine Cervix
(930)
A Kojima, Y Mikami, T Sudo, S Yamaguchi, Y Kusanagi, M Ito, R Nishimura Ehime University, Matsuyama, Ehime, Japan; Kyoto University Hospital, Kyoto, Japan; Hyogo Medical Center for Adults, Akashi, Hyogo, Japan
| Add |
| 11:15 |
Use of p57KIP2 and Ki-67 Immunohistochemistry and Interphase FISH in the Diagnosis of Hydatidiform Mole: A Unique Algorithmic Approach
(864)
TS Barry, PM Kim, DO Treaba, SE Tirrell, SJ Kussick, CH Tse, PL Kandalaft, AM Gown PhenoPath Laboratories, PLLC and IMPRIS, Seattle, WA
| Add |
| 11:30 |
Human Placental Site Trophoblastic Tumor: Novel Genetic Mode of Oncogenesis That Excludes the Presence of Y Chromosome
(916)
P Hui, HL Wang, PG Chu, B Yang, J Huang, RN Baergen, XM Yang, RA Soslow Yale University, New Haven, CT; Washington University, St Louis, MO; City of Hope National Medical Center, Duarte, CA; Cleveland Clinic Foundation, Cleveland, OH; University of Rochester, Rochester, NY; Weil Medical College of Cornell University, NY, NY; Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, NY, NY
| Add |
| 11:45 |
The Histogenesis of Choriocarcinoma — An Immunohistochemical Study
(946)
TL Mao, RJ Kurman, CC Huang, MC Lin, IM Shih Johns Hopkins Meidcal Institutions, Baltimore, MD; National Taiwan University Hospital, Taipei, Taiwan; Chang Gung Memorial Hospital, Kaohsiung, Taiwan
| Add |
|
|
